Table 1.
Baseline characteristics
| Unmatched cohort |
PSM cohort |
|||||
|---|---|---|---|---|---|---|
| HL (N = 1,459) | TFL (N = 470) | ASMD | HL (N = 247) | TFL (N = 247) | ASMD | |
| Age, median [IQR] | 69 [64, 75] | 68 [62, 74] | 0.288 | 67 [62.5, 73] | 68 [62, 73.5] | 0.066 |
| Prostate volume (ml), n (%) | 0.482 | 0.061 | ||||
| 80–100 | 388 (26.6) | 64 (11.8) | 19 (7.7) | 23 (9.3) | ||
| 101–200 | 939 (64.4) | 427 (78.6) | 203 (82.2) | 198 (80.2) | ||
| >200 | 132 (9.0) | 52 (9.6) | 25 (10.1) | 26 (10.5) | ||
| Preoperative indwelling catheter, n (%) | 296 (20.3) | 65 (12.0) | 0.318 | 23 (9.3) | 27 (10.9) | 0.054 |
| Preoperative IPSS, median [IQR] | 26 [22, 29] | 23 [21, 24] | 0.490 | 24 [22, 26] | 23 [21, 26] | 0.007 |
| Preoperative QOL, median [IQR] | 5.0 [5.0, 5.0] | 4.0 [3.0, 5.0] | 0.869 | 5.0 [4.0, 5.0] | 4.0 [4.0, 5.0] | 0.578 |
| Preoperative Qmax, median [IQR] | 8.0 [7.0, 10] | 8.5 [7.0, 10.8] | 0.124 | 9.0 [7.0, 11] | 8.6 [7.1, 11] | 0.074 |
| Preoperative PVR, median [IQR] | 69 [58, 80] | 70 [55, 90] | 0.151 | 69 [57, 90] | 70 [60, 100] | 0.205 |
ASMD, absolute standardized mean difference; HL, holmium laser; IPSS, International Prostate Symptom Score; IQR, interquartile range; PSM; propensity score matched; PSM, propensity score matched; PVR, post-void residual urine volume; Qmax, peak flow rate; QoL, quality of life score; TFL, thulium fiber laser.